The Global Molecular FISH Testing Market is estimated to witness a rise in its revenue from US$ 645.2 Mn in 2021 to US$ 978.6 Mn by 2027. The market is registering a CAGR of 7.2% over the forecast period 2022-2027. Fluorescence in situ hybridization (FISH) is a ‘molecular cytogenetic technique in which using molecular probes, any type of chromosomal abnormalities can be encountered precisely by hybridization. The karyotyping takes at least 3 to 4 days to complete the entire process while the FISH method is rapid, one can get results within a day. The cell culture process is not needed for performing FISH which is one of its most important advantages. Identification of specific chromosomal abnormality, especially structural as well as numerical; chromosomal deletion, duplication, and translocation can be detected using fluorescence in situ hybridization. By using variations like SKY and M-FISH, new non-random genetic abnormalities can be identified as well.
The market is majorly driven by factors such as the increasing prevalence of genomic abnormalities & cancers and the growing adoption of new techniques for molecular-based cytogenetics. Often parents of children with a developmental disability want to know more about their child's conditions before choosing to have another child. These concerns can be addressed by analysis of the parent's and child's DNA. In cases where the child's developmental disability is not understood, the cause of it can potentially be determined using FISH and cytogenetic techniques. Examples of diseases that are diagnosed using FISH include Prader-Willi syndrome, Angelman syndrome, 22q13 deletion syndrome, chronic myelogenous leukemia, acute lymphoblastic leukemia, Velocardiofacial syndrome, and down syndrome. Furthermore, FISH can be used to form a diagnosis, evaluate prognosis, or evaluate remission of a disease, such as cancer. Treatment can then be specifically tailored. Therefore, the demand for FISH Probes in the medical sector has been increasing due to their function in analyzing biomarkers in tumor cells. Moreover, the growing adoption of new techniques for molecular-based cytogenetics is also propelling the market growth. By using variations like SKY and M-FISH, new non-random genetic abnormalities can be identified as well. Spectral karyotyping or multicolor FISH is a modification of native FISH in which using the different colored sequence-specific probe each chromosome can be painted thus, chromosomal rearrangement can be encountered precisely. However, the high cost of FISH probes poses a challenge to market growth.
Key Insights of the Report:
Key Takeaways from the Global Molecular FISH Testing Market Report:
Competitive Insight
The key players in the Global Molecular FISH Testing Market are Thermo Fisher, Abbott Laboratories, Agilent, Oxford Gene Technology, and ARUP Laboratories, among others. Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions in order to have a grip on the emerging markets. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.
Segmentation Overview
The following are the different segments of the Global Molecular FISH Testing Market:
By Technology segment of the Global Molecular FISH Testing Market is sub-segmented into:
By Probe Type segment of the Global Molecular FISH Testing Market is sub-segmented into:
By Cellular Stains segment of the Global Molecular FISH Testing Market is sub-segmented into:
By Application segment of the Global Molecular FISH Testing Market is sub-segmented into:
By End User segment of the Global Molecular FISH Testing Market is sub-segmented into:
By Region segment of the Global Molecular FISH Testing Market is sub-segmented into:
Report Attribute | Details |
---|---|
Market Size Value in 2021 | US$ 645.2 Mn |
Expected Revenue in 2027 | US$ 978.6 Mn |
Historic Data | 2017-2020 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Unit | Value (USD Mn) |
CAGR | 7.2% |
Segments covered | By Technology, Probe Type, Cellular Stains, Application, End-User, and Region |
Leading players | Thermo Fisher, Abbott Laboratories, Agilent, Oxford Gene Technology, and other prominent players. |
Customization Scope | Get your customized report as per your preference. Ask for customization |
Identification of specific chromosomal abnormality especially structural as well as numerical; chromosomal deletion, duplication, and translocation can be detected using the fluorescence in situ hybridization (FISH).
The karyotyping takes at least 3 to 4 days to complete the entire process while the FISH method is rapid, one can get results within a day. Further, the cell culture process is not needed for performing FISH which is one of its most important advantages.
Flow FISH, Q FISH, imuno FISH, and cryo FISH are the various technology types of FISH test.
The Global Molecular FISH Testing Market was valued at US$ 645.2 Mn in 2021.
The Global Molecular FISH Testing Market is estimated to expand at a CAGR of 7.2% over the projection period.
The market is majorly driven by factors such as increasing prevalence of genomic abnormalities & cancers and growing adoption of new techniques for molecular-based cytogenetics.
One of the biggest challenges of using FISH Techniques is its high cost.
Investments in pharmacogenomics and pharmaceutical research is expected to provide a lucrative opportunity for market expansion.
Cryo FISH technology has the highest share in the Global Molecular FISH Testing Market.
Cancer research is the highest application segment in the Global Molecular FISH Testing Market.
North America dominates the Global Molecular FISH Testing Market.
The key players in the Global Molecular FISH Testing Market are Thermo Fisher, Abbott Laboratories, Oxford Gene Technology and ARUP Laboratories among others.